- $4.27bn
- $5.37bn
- $2.61bn
- 69
- 37
- 93
- 73
Annual income statement for Lazard, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,667 | 2,647 | 3,274 | 2,855 | 2,611 |
| Cost of Revenue | |||||
| Gross Profit | 2,473 | 2,463 | 3,063 | 2,664 | 2,423 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,274 | 2,145 | 2,550 | 2,338 | 2,691 |
| Operating Profit | 393 | 502 | 724 | 517 | -80 |
| Net Income Before Taxes | 393 | 502 | 724 | 517 | -80 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 298 | 403 | 543 | 392 | -57.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 287 | 402 | 528 | 358 | -75.5 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 283 | 401 | 526 | 354 | -79.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.58 | 3.62 | 4.67 | 3.54 | 0.781 |
| Dividends per Share |